Close
Close
Treatment Database
N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-4-(2-fluorophenyl)-2-methyloxazole-5-carboxamide
Trade Name not avaiable
Orphan Indication Idiopathic Pulmonary Fibrosis
USA Market Approval
USA Designation Date 22-07-2019
Sponsor Blade Therapeutics, Inc.
442 Littlefield Avenue
South San Francisco, California, 94080
More about Idiopathic pulmonary fibrosis
Free Newsletter
Related Videos
by Abidemi Uruejoma
482 views